Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNotes PayablesOther Non-Current AssetsPayablesPrepaid AssetsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Cavitation Technologies (CVAT) Common Equity (2016 - 2025)

Cavitation Technologies' Common Equity history spans 15 years, with the latest figure at -$248000.0 for Q4 2025.

  • On a quarterly basis, Common Equity fell 978.26% to -$248000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was -$248000.0, a 978.26% decrease, with the full-year FY2025 number at $69000.0, up 114.37% from a year prior.
  • Common Equity hit -$248000.0 in Q4 2025 for Cavitation Technologies, down from -$189000.0 in the prior quarter.
  • Over the last five years, Common Equity for CVAT hit a ceiling of $1.0 million in Q2 2022 and a floor of -$1.2 million in Q4 2023.
  • Historically, Common Equity has averaged -$81650.0 across 5 years, with a median of -$106000.0 in 2024.
  • Biggest five-year swings in Common Equity: skyrocketed 352.07% in 2022 and later crashed 978.26% in 2025.
  • Tracing CVAT's Common Equity over 5 years: stood at $378000.0 in 2021, then skyrocketed by 75.66% to $664000.0 in 2022, then crashed by 278.61% to -$1.2 million in 2023, then surged by 98.06% to -$23000.0 in 2024, then crashed by 978.26% to -$248000.0 in 2025.
  • Business Quant data shows Common Equity for CVAT at -$248000.0 in Q4 2025, -$189000.0 in Q3 2025, and $69000.0 in Q2 2025.